The largest database of trusted experimental protocols

7 protocols using 96 well

1

Evaluating Antifungal Effects of Pom-1 Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antifungal effect of Pom-1A to Pom-1F on Candida spp. biofilm formation can be determined following the Clinical and Laboratory Standard Institute guidelines (M27-A3) [67 ]. For this, 2.5 × 103 yeast cells were incubated in 200 µL of RPMI-1640 medium supplemented with L-glutamine, fluconazole, amphotericin B, and Pom-1A to Pom-1F. Incubation was performed on flat-bottomed polystyrene microplates with 96 wells (Sarstedt AG & Co. KG, Nümbrecht, Germany) for 24 h at 37 °C without shaking. The subsequent treatment with crystal violet was originally developed by George O’Toole for bacteria and adapted to Candida biofilms [68 (link)]. For this purpose, the planktonic phase was removed, and the wells were washed twice with 200 µL of demineralized water. The remaining biofilm cells were treated with 200 µL of 0.1% (w/v) crystal violet solution for 15 min. After removing the solution, they were washed again twice with 200 µL demineralized water, and the microtiter plates were dried for at least 24 h at 25 °C. The stain was dissolved with 200 µL of 30% acetic acid and transferred to a new plate after 15 min. The absorbance at 560 nm was measured using a Tecan Infinite F200 microplate reader (Tecan Group Ltd., Männedorf, Switzerland). The resulting data were evaluated against the untreated controls so that the efficacy of the agents could be determined.
+ Open protocol
+ Expand
2

Angicin's Antifungal Effect on Candida

Check if the same lab product or an alternative is used in the 5 most similar protocols
A resazurin assay was used to detect the antifungal effect of Angicin on the viability of Candida cells. Therefore, 2.5 × 103 cells were incubated in 200 μl RPMI-1640 medium with 300 mg/l L-glutamine and two different Angicin concentrations (25 μg/ml, 100 μg/ml) at 37°C for 24 h in a flat-bottomed polystyrene microtiter plate with 96 wells (Sarstedt AG & Co., KG, Nümbrecht, Germany) with shaking at 900 rpm on an Eppendorf shaker. For the following quantification of viable cells, a resazurin-Reduction-Assay was performed. In brief, 20 μl of 0.15 mg/ml resazurin (Sigma-Aldrich) solution was added per well and incubated for 2 h at 37°C while shaking at 900 rpm. Fluorescence measurement (excitation wavelength 535 nm, emission wavelength 595 nm) of the resulting resorufin (viable cells are able to reduce resazurin to resorufin) was then performed by using a Tecan infinite F200 microplate reader (Tecan Group). The resulting data were normalized to the untreated control and the efficacy of Angicin was determined.
+ Open protocol
+ Expand
3

Cytotoxic Effects of PYDP on Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro cytotoxic effects of PYDP on colorectal adenocarcinoma cell lines (HT‐29), breast cancer cell lines (MCF‐7) and mouse fibroblast (3T3‐L1) cell line were measured by the XTT method according to the manufacturer‘s instructions (Cell Proliferation XTT Kit, BI). The cells were seeded in 96‐well (Sarstedt, Numbrecht, Germany) at a density of 10,000 cells/well in a total volume of 100 μL. After 2 h of incubation (at 37 °C in a 95 % humidity and in an atmosphere containing 5 % CO2), the medium was removed from the adherent cells and the wells were washed with 50 μL PBS buffer. Then, 50 μL of fresh medium was added per well followed by 50 μL of the sample (PYDP) at two concentrations (100–250 μM). After 24 h of incubation, the medium in each well was removed. Then, 100 μL of basal medium and 50 μL XTT solution were added to each well. To the control wells, 100 μL of complete medium containing 0.2 % DMSO was added. The plate was placed in a CO2 incubator for 5–6 h. Finally, the absorbances at 450 nm (reference filter at 650 nm) were measured in an ELISA reader (Anthos‐HTII) and cell viability in the wells was calculated.
+ Open protocol
+ Expand
4

Cell Culture Protocols for Beta-Thalassemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two human beta-thalassemia reporter cell lines—HeLa pLuc 705 [13 (link)] and HeLa EGFP 654 [14 (link),51 ]—were used. For siRNA assay, we used luciferase-expressing cell line—U-87 MG-Luc2 [52 ]. Cells were cultured at 37 °C in Dulbecco’s Modified Eagle Medium (DMEM) (BioWhittaker, Lonza Group, Basel, Switzerland, or Sigma-Aldrich) that contained 4.5 g/L of glucose and was supplemented with 10% (v:v) of fetal bovine serum (FBS) and 1% (v:v) of penicillin–streptomycin solution (100 U/mL penicillin and 100 μg/mL streptomycin) (further “growth medium”). Cells were grown on 10 cm cell culture plates (Corning, Corning, NY, USA) in a humid atmosphere that contained 5% of CO2 and were split every second day. For detaching of cells, trypsin-EDTA solution was used (Corning). Cells were washed with Dulbecco’s Phosphate-Buffered Saline (DPBS) without calcium and magnesium (Corning). For experiments, cells were plated on 12-well (Greiner Bio-One, Kremsmünster, Austria), 24-well (VWR, Radnor, PA, USA) or 96-well (Sarstedt, Nümbrecht, Germany) plates. All the operations with cells were performed in a sterile cell culture hood.
+ Open protocol
+ Expand
5

Cell Culture and Transfection Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293, HEK 293 Flp-In T-REx, and HeLa cells were grown in DMEM supplemented with 10% fetal calf serum (Life Technologies). PC9 cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum. For ELISA assay, cells were seeded in 96-well (Sarstedt AG & Co) or 384-well plates (Greiner Bio-One) with 15,000 (96 well) or 5000 (384 well) cells per well. Cells were transfected with various plasmids with polyethylenimine (PEI) Max (Polysciences)48 (link). Expression in HEK 293 Flp-In T-REx cells was induced by treating the cells with tetracycline (1 µg/ml) for 6–16 h. For experiments to study signaling pathway activation, the cells were starved with 0.1% fetal calf serum as well as treated with tetracycline for 6 h before stimulation with EGF (Sigma-Aldrich), tetradecanoylphorbol acetate (TPA) (Sigma-Aldrich), or anisomycin (Sigma-Aldrich). Stable cell lines were created according to the manual of Flp-In T-REx (Invitrogen). Briefly, plasmid containing both bait and prey DNA and pOG44 plasmid (1:10 ratio) were cotransfected into HEK 293 Flp-In T-REx cells. After 3 days, the cells underwent puromycin selection. Single colonies were selected and the expression of bait and prey were verified by western blot analysis.
+ Open protocol
+ Expand
6

Cell Culture for Gene Silencing and Splice Correction

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the splice-correction assay, two human beta-thalassemia reporter cell lines, i.e., HeLa pLuc 705 [52 (link)] and HeLa EGFP 654 [53 (link),54 ], were used. For the gene-silencing assay, a luciferase-expressing cell line, i.e., U87 MG-Luc2 [55 ], was used. The cells were cultured at 37 °C in Dulbecco’s Modified Eagle Medium (DMEM) (Corning, Corning, NY, USA) containing 4.5 g/L of glucose and supplemented with 10% (v:v) of fetal bovine serum (FBS) and 1% (v:v) of a penicillin–streptomycin solution (100 U/mL penicillin and 100 g/mL streptomycin). The cells were grown on 6 cm cell culture dishes (Corning) in a humid atmosphere that contained 5% CO2. The cells were split every second day. To detatch the cells, trypsin-EDTA solution (Corning) was used. The cells were washed with Dulbecco’s Phosphate-Buffered Saline (DPBS) without calcium and magnesium (Corning). To conduct the experiments, the cells were plated on 96-well (Sarstedt, Nümbrecht, Germany) or 24-well (CytoOne, Hamburg, Germany) plates. All of the operations using cells were performed in a sterile cell culture hood.
+ Open protocol
+ Expand
7

Cell Culture Conditions for Beta-Thalassemia Reporter Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two human beta-thalassemia reporter cell lines -HeLa pLuc 705 [13] and HeLa EGFP 654 [14, 51] were used. For siRNA assay, we used luciferase-expressing cell line -U-87 MG-Luc2 [52] . Cells were cultured at 37 o C in Dulbecco's Modified Eagle Medium (DMEM) (BioWhittaker, USA, or Sigma-Aldrich, UK) that contained 4.5 g/L of glucose and was supplemented with 10% (v:v) of fetal bovine serum (FBS) and 1% (v:v) of penicillin-streptomycin solution (100 U/mL penicillin and 100 μg/mL streptomycin) (further "growth medium"). Cells were grown on 10 cm cell culture plates (Corning, USA, NY) in the humid atmosphere that contained 5% of CO2 and were split every second day. For detaching cells, trypsin-EDTA solution was used (Corning, USA, NY). Cells were washed with Dulbecco's Phosphate-Buffered Saline (DPBS) without calcium and magnesium (Corning, USA, NY). For experiments, cells were plated on 12-well (Greiner Bio-One, Germany), 24-well (VWR, USA, PA) or 96-well (Sarstedt, Germany) plates. All the operations with cells were performed in sterile cell culture hood.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!